Hyperglycemia and diabetes are common in hospitalized patients. Managing that amid the restrictions of the COVID-19 pandemic, including the more recent staff shortages, has been extremely difficult at the VA and elsewhere. Increased use of continuous glucose monitoring has helped the situation.
More than two years into the pandemic, studies are showing the long-term effects COVID-19 can have on the heart, lungs, kidneys and other organ systems.
A potential protective role for suppression of the androgen receptor (AR) against COVID-19 incidence and severity has been observed in some retrospective analyses.
Clinicians are often wary of suggesting that older patients discontinue some of their medications, believing they will get pushback.
While it is recognized that patients with nonalcoholic fatty liver disease who also have Type 2 diabetes mellitus (DM) have a high risk of progression to hepatocellular carcinoma. Exactly what causes the higher risks remain unclear, however, according to a new study.
